![Jeffrey James Roix](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey James Roix
Amministratore Delegato presso
Stingray Bio Ltd.
Profilo
Jeffrey James Roix currently works at Stingray Bio Ltd., as Chief Executive Officer, Opal Therapeutics Ltd., as Director from 2021, and o2h Ltd, as Venture Partner from 2020.
Mr. Roix also formerly worked at NeoPhore Ltd., as Chief Executive Officer & Director and PhoreMost Ltd., as Chief Operating Officer from 2015 to 2018.
Mr. Roix received his undergraduate degree from Harvard Extension School.
Posizioni attive di Jeffrey James Roix
| Società | Posizione | Inizio |
|---|---|---|
Stingray Bio Ltd.
 Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Amministratore Delegato | - |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Investitore di Private Equity | 01/07/2020 |
Opal Therapeutics Ltd.
 Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Direttore/Membro del Consiglio | 01/03/2021 |
Precedenti posizioni note di Jeffrey James Roix
| Società | Posizione | Fine |
|---|---|---|
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Direttore operativo | 01/04/2018 |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Amministratore Delegato | - |
Formazione di Jeffrey James Roix
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
4
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Harvard Extension School
 Harvard Extension School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
Opal Therapeutics Ltd.
Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Commercial Services |
Stingray Bio Ltd.
Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Commercial Services |
